PNC Financial Services Group
ALLO icon

PNC Financial Services Group’s Allogene Therapeutics ALLO Stock Holding History

PNC Financial Services Group’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-3,057
Closed -$7.46K – 5217
2026
Q1 		$7.46K Buy
+3,057
New +$6.13K ﹤0.01% 4084
2025
Q3 		– Sell
-85
Closed -$96 – 5086
2025
Q2 		$96 Sell
85
-257
-75% -$342 ﹤0.01% 4838
2025
Q1 		$499 Buy
342
+154
+82% +$290 ﹤0.01% 4646
2024
Q4 		$400 Buy
188
+10
+6% +$25 ﹤0.01% 4562
2024
Q3 		$498 Sell
178
-2,500
-93% -$6.67K ﹤0.01% 4567
2024
Q2 		$6.24K Hold
2,678
– – ﹤0.01% 3931
2024
Q1 		$12K Hold
2,678
– – ﹤0.01% 3678
2023
Q4 		$8.6K Sell
2,678
-194
-7% -$550 ﹤0.01% 3778
2023
Q3 		$9.1K Buy
2,872
+372
+15% +$1.63K ﹤0.01% 3793
2023
Q2 		$12.4K Sell
2,500
-31
-1% -$168 ﹤0.01% 3778
2023
Q1 		$12.5K Hold
2,531
– – ﹤0.01% 3709
2022
Q4 		$15.9K Hold
2,531
– – ﹤0.01% 3582
2022
Q3 		$27K Hold
2,531
– – ﹤0.01% 3299
2022
Q2 		$29K Sell
2,531
-450
-15% -$4K ﹤0.01% 3295
2022
Q1 		$27K Buy
2,981
+17
+0.6% +$177 ﹤0.01% 3430
2021
Q4 		$44K Buy
2,964
+14
+0.5% +$247 ﹤0.01% 3173
2021
Q3 		$76K Sell
2,950
-19
-0.6% -$451 ﹤0.01% 2808
2021
Q2 		$77K Buy
2,969
+19
+0.6% +$542 ﹤0.01% 2805
2021
Q1 		$104K Hold
2,950
– – ﹤0.01% 2553
2020
Q4 		$74K Hold
2,950
– – ﹤0.01% 2668
2020
Q3 		$111K Buy
2,950
+450
+18% +$17K ﹤0.01% 2262
2020
Q2 		$107K Buy
+2,500
New +$90.4K ﹤0.01% 2286

Other funds holding ALLO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $5B AUM 58.56% 1-Year Est. Return
SCM
Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

PNC Financial Services Group's ALLO Position: Q2 2026 in Review

PNC Financial Services Group sold out of Allogene Therapeutics (ALLO) in Q2 2026, closing a stake of 3,057 shares — an estimated $7.46K sold.

PNC Financial Services Group first reported a position in ALLO in Q2 2020 and held it in 22 quarters. The position peaked at $111K in Q3 2020. 209 funds tracked by Wall St. Rank hold ALLO as of Q2 2026.

  • PNC Financial Services Group reported no remaining Allogene Therapeutics position as of Q2 2026 after selling out during the quarter.
  • PNC Financial Services Group sold 3,057 Allogene Therapeutics shares in Q2 2026, an estimated $7.46K.
  • PNC Financial Services Group first reported a position in Allogene Therapeutics in Q2 2020 and held it in 22 quarters.
  • PNC Financial Services Group's Allogene Therapeutics position peaked at $111K in Q3 2020.
  • 209 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.